Holen Sie sich die Stockscreener-App
22.09
0.96%
0.21
Handel nachbörslich:
22.09
Schlusskurs vom Vortag:
$21.88
Offen:
$22
24-Stunden-Volumen:
409.35K
Relative Volume:
1.96
Marktkapitalisierung:
$412.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.62%
1M Leistung:
-2.41%
6M Leistung:
-35.82%
1J Leistung:
+36.19%
1-Tages-Spanne:
$21.31
$22.75
1-Wochen-Bereich:
$20.00
$23.40
52-Wochen-Spanne:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Vergleichen Sie TECX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
22.09 | 409.42M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-21 | Eingeleitet | Mizuho | Outperform |
| 2024-11-20 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | TD Cowen | Buy |
| 2023-12-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-05 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Buy |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-03-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-16 | Eingeleitet | Wedbush | Outperform |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Published on: 2025-08-13 09:01:10 - Newser
Tectonic Therapeutic Inc. stock chart pattern explainedMarket Trend Report & Growth Oriented Trading Recommendations - Newser
Using Python tools to backtest Tectonic Therapeutic Inc. strategiesShare Buyback & Real-Time Volume Spike Alerts - Newser
What does recent volatility data suggest for Tectonic Therapeutic Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser
Combining price and volume data for Tectonic Therapeutic Inc.Earnings Miss & Low Drawdown Momentum Trade Ideas - Newser
Tectonic Therapeutic Inc. stock retracement – recovery analysis2025 Year in Review & Fast Exit and Entry Strategy Plans - Newser
Risk adjusted return profile for Tectonic Therapeutic Inc. analyzedCPI Data & Accurate Technical Buy Alerts - Newser
Combining machine learning predictions for Tectonic Therapeutic Inc.Low Drawdown Stock Screener with Analysis - Newser
What institutions are buying Tectonic Therapeutic Inc. stock nowFree Low Risk Equity Screener With Results - Newser
Sectors Driving Future Growth for Tectonic Therapeutic Inc. StockAI Triggered Buy Zone Forecast System - Newser
How Tectonic Therapeutic Inc. stock performs during market volatilityAI Volatility Forecast and Risk Monitor - Newser
Real time breakdown of Tectonic Therapeutic Inc. stock performanceTechnical Trend Forecast for Investors - Newser
Healthcare Analysts Bullish on Top Stocks: Tectonic Therapeutic, Ascend Wellness, Rocket Pharmaceuticals - AInvest
What makes Tectonic Therapeutic Inc. stock price move sharplyRisk-Managed Strategy Based on Price Analysis - Newser
Full technical analysis of Tectonic Therapeutic Inc. stockEarnings Report Summary with Market Impact - Newser
Regression analysis insights on Tectonic Therapeutic Inc. performanceBuy and Hold Position Summary Review - Newser
How moving averages guide Tectonic Therapeutic Inc. tradingFree Risk Managed Intraday Trade Alerts - Newser
How to escape a deep drawdown in Tectonic Therapeutic Inc.Intraday Strategy with Real Time Monitoring - Newser
Using data models to predict Tectonic Therapeutic Inc. stock movementFree Oversold Bounce Stock Play Ideas - Newser
What analysts say about Tectonic Therapeutic Inc. stock outlookRisk Adjusted Trade Signal Screening Tool - Newser
Is Tectonic Therapeutic Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Low Volatility Stable Growth Picks - Newser
Historical volatility pattern of Tectonic Therapeutic Inc. visualizedFree Weekly Hot Picks With Buy Confidence - Newser
How to forecast Tectonic Therapeutic Inc. trends using time seriesFast Entry Strategy with Price Prediction - Newser
Why Tectonic Therapeutic Inc. stock attracts strong analyst attentionMarket Correction Proof Stock Screening Analysis - Newser
Tectonic Therapeutic Reports Q2 Financial Results - The Globe and Mail
Tectonic Therapeutic Inc. Reports Increased Cash Reserves - TipRanks
Tectonic (TECX) Q2 R&D Soars 142% - AOL.com
Tectonic (TECX) Q2 R&D Soars 142% - The Motley Fool
Risk vs reward if holding onto Tectonic Therapeutic Inc.Free Low Risk Buy Zone Opportunity Watch - Newser
Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Clinical Trial Success: TX45 Shows 19% PCWP Drop, Plans New PH-ILD Phase 2 Study - Stock Titan
Comparing Tectonic Therapeutic Inc. in custom built stock radarsStock Portfolio Risk and Return Analysis - Newser
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Es liegen keine Finanzdaten für Tectonic Therapeutic Inc (TECX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):